Ebitda

Rediff.com » News » Ebitda

News for Ebitda

Business

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's......

Jio IPO may be pegged at over $6 bn; listing expected in Q2 or Q3 of 2025

Reliance Jio, the telecom business of the Mukesh Ambani-promoted conglomerate, is expected to go for an initial public offering (IPO) of over $6.25 billion either in the second or the third quarter......

Dabur stock fall may provide entry to long-term investors

Dabur’s performance in the July-September quarter of the current financial year (Q2FY25) was weak but in line with consensus. Consolidated revenue declined 5 per cent year-on-year (Y-o-Y)......

FMCG firms worry over high inflation; price hike likely

Leading FMCG companies reported a decline in margins in the September quarter on account of higher input costs and food inflation, which ultimately slowed down the pace of urban consumption.......

India Inc revenue growth in Q2 likely slowest in 4 years

The revenue growth of Indian companies for the July-September quarter is estimated to be 5-7 per cent year-on-year (Y-o-Y), marking the slowest growth in 16 quarters, rating agency CRISIL said on......

Rediff News

Ebitda

News for Ebitda

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Jio IPO may be pegged at over $6 bn; listing expected in Q2 or Q3 of 2025

Dabur stock fall may provide entry to long-term investors

FMCG firms worry over high inflation; price hike likely

India Inc revenue growth in Q2 likely slowest in 4 years

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS